ASX Announcement 26 October 2026 Quarterly Report Webinar 11am (AEDT) Monday 2 November 2026 ReNerve Limited (ASX, "ReNerve" or "the Company"), an Australian biotechnology company developing innovative products for peripheral nerve injury ("PNI") repair, is hosting an investor webinar to provide an...
Quarterly Report Webinar
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Renerve
- Q1 FY27 Activities Report and Appendix 4C
- Positive 12-Month Data for NervAlign Nerve Guide Matrix
- Positive FDA Feedback on NervAlign Nerve Guide Matrix
- Change of Director's Interest Notice - P Savage
- Change of Director's Interest Notice - M McGuire
Later from Renerve
- Notification regarding unquoted securities - RNV
- Becoming a substantial holder
- Quarterly Investor Presentation
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve